Table 2 Differences in immunosuppressant use and the pregnancy outcome
Non-pregnant (n = 19) | Clinical pregnancy (n = 21) | P value | ||
|---|---|---|---|---|
0.73 | ||||
Regimen | CI | 3 (15.8%) | 6 (28.6%) | |
CI + ST + AP | 7 (36.8%) | 5 (23.8%) | ||
CI + ST | 8 (42.1%) | 9 (42.9%) | ||
CI + AP | 1 (5.3%) | 1 (4.8%) | ||
Immunosuppressant use | CyA | 5 (26.3%) | 9 (42.9%) | 0.27 |
TAC | 13 (68.4%) | 12 (57.1%) | 0.46 | |
DFZ | 10 (52.6%) | 2 (9.5%) | 0.003 | |
Pred | 8 (42.1%) | 13 (61.9%) | 0.21 | |
Aza | 5 (26.3%) | 2 (9.5%) | 0.16 | |
MMF | 4 (21.1%) | 4 (19%) | 0.87 |